Impact of Combined Treatment with ARNi and SGLT2i on Clinical and Echocardiographic Outcomes in Patients with CRT During Mid-term Period
The combined treatment with SGLT2i and ARNi in patients with CRT improved the echocardiographic and clinical outcomes during the 12-month follow-up. In our study cohort, the CRT response was associated with non-ischemic HF and combined treatment with ARNi and SGLT2i.
Authors
- Т. A. Atabekov (ORCID: https://orcid.org/0000-0003-2645-4142)
- Р. Е. Баталов (ORCID: https://orcid.org/0000-0003-1415-3932)
- М. С. Хлынин (ORCID: https://orcid.org/0000-0002-9885-5204)
- С. В. Попов (ORCID: https://orcid.org/0000-0002-9050-4493)
- С. Н. Криволапов (ORCID: https://orcid.org/0000-0001-8121-8287)
Institutions
- Russian Academy of Sciences (RU)
- Tomsk National Research Medical Center (RU)
Publication Details
- Journal
- Current Cardiology Reviews
- Published
- 2025-03-19
- DOI
- https://doi.org/10.2174/011573403x350660250203111206
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00